NCT06937827

Brief Summary

The transition period from hospital to home is a time of heightened risk for patients to experience adverse events, medication errors, and readmission to the hospital. Patients at the highest risk include older adults and patients with low health literacy, socioeconomic disadvantages, and/or multiple comorbidities. This project proposes to expand the existing Transitions of Care Clinic (TOCC) which was recently introduced in our institution in 2024, to bridge the gap in care between hospital discharge to home and connect discharged patients to their outpatient providers with a focus on patients with heart failure (HF). The existing TOCC, a multidisciplinary team composed of a pharmacist and a nurse practitioner, seeks to improve the services that are currently being provided to patients and enhance the transitions of care process by providing patients with education, tools, and resources to help manage their chronic disease. With this study, we propose to expand TOCC by offering extensive education to patients via iPad videos and providing them with HF tool kits prior to their discharge. We will also assist with scheduling follow appointments with their outpatient providers and follow up with patients after the appointment takes place to re-evaluate their needs and reinforce self management of heart failure. By targeting patients being treated for acute exacerbation of heart failure with preserved ejection fraction (HFpEF), this study aims to facilitate the transition of care, reduce hospital readmissions and improve patients' quality of life and satisfaction. Patients with HFpEF represent a majority of the HF patients that are readmitted at OUMC. HFpEF patients have fewer guideline recommended treatments and represent a vulnerable patient population. The HF tool kits will provide these patients with the essential tools, resources, and log sheets for self-management such as monitoring daily weights, monitoring blood pressure and heart rate. Patients provided with a kit will receive an initial phone call from TOCC within 1 to 3 days of discharge and a second phone call within 21-24-days post discharge.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
11mo left

Started Jun 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Jun 2025Apr 2027

First Submitted

Initial submission to the registry

April 14, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 22, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

June 26, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2027

Last Updated

February 11, 2026

Status Verified

February 1, 2026

Enrollment Period

1.8 years

First QC Date

April 14, 2025

Last Update Submit

February 9, 2026

Conditions

Keywords

Discharge plansheart failure with preserved ejection fractionReadmissionstransition of care

Outcome Measures

Primary Outcomes (1)

  • All-cause 30-day hospital readmission rate for heart failure

    This measures the percentage of patients initially hospitalized for HF who are readmitted to the hospital for any reason within 30 days of discharge. This is a standard metric for evaluating HF care and aligns directly with the objective of reducing readmissions.

    30 days post discharge

Secondary Outcomes (2)

  • 7-Day Provider Follow-Up

    7 day post discharge

  • Patient Satisfaction with Transition of Care

    31 to 45 days post discharge

Study Arms (2)

Active Cohort - Heart Failure (HF) Kit

EXPERIMENTAL

Extensive education to patients via iPad videos and providing them with HF kits prior to their discharge. Structured follow up post discharge and linkage to care.

Behavioral: HF Kit and Follow-ups

Historical controls

NO INTERVENTION

Standard of care education and follow up

Interventions

These patients will receive TOCC intervention, which includes: pre-discharge introduction to the program; watching educational videos about heart failure via Mytonomy; receiving the American Heart Association's "Get With The Guidelines" (GWTG) booklet and a heart failure (HF) kit. These patients will receive a follow-up phone call days 1 to 3 days post discharge from the pharmacist and nurse practitioner to review discharge instructions, provide medication education, and assess clinical status; a second follow-up call will be conducted days 21 to 24 post discharge. The HF tool kits will provide these patients with the essential tools, resources, and log sheets for self-management such as monitoring daily weights, monitoring blood pressure and heart rate

Active Cohort - Heart Failure (HF) Kit

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults ages 18 to 90 years old discharged from Ocean University Medical Center (OUMC)
  • Inpatient admission for heart failure with preserved ejection fraction (HFpEF) exacerbation
  • Patient discharged home with or without homecare

You may not qualify if:

  • Refuse to participate in TOCC phone calls
  • Discharged to a facility
  • Discharged with homecare services
  • Discharged on hospice services
  • Hemodialysis
  • Leave against medical advice (AMA)
  • Pregnant
  • Diagnosed with dementia
  • Without medical capacity or unable to provide own consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ocean University Medical Center

Brick, New Jersey, 08724, United States

RECRUITING

Study Officials

  • Alexandria Berns, PharmD

    Hackensack Meridian Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alexandria Berns, PharmD

CONTACT

Tina Wismar, MSN, FNP-BC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Active cohort will be compared to historical controls
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 14, 2025

First Posted

April 22, 2025

Study Start

June 26, 2025

Primary Completion (Estimated)

April 15, 2027

Study Completion (Estimated)

April 15, 2027

Last Updated

February 11, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations